Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000465196 | SCV000527024 | benign | not provided | 2020-09-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001086614 | SCV000559755 | benign | Charcot-Marie-Tooth disease axonal type 2O | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002318458 | SCV000850662 | benign | Inborn genetic diseases | 2016-10-21 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV004999399 | SCV001143806 | benign | not specified | 2024-09-24 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002488930 | SCV002795865 | likely benign | Autosomal dominant childhood-onset proximal spinal muscular atrophy without contractures; Charcot-Marie-Tooth disease axonal type 2O; Intellectual disability, autosomal dominant 13 | 2022-05-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003959933 | SCV004769370 | benign | DYNC1H1-related disorder | 2023-05-31 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |